Cullinan Therapeutics Inc. (CGEM) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-09
3:43 pm
Purchase
2021-12-3113GCULLINAN THERAPEUTICS INC
CGEM
VANGUARD GROUP INC2,366,808
5.420%
2,366,808increase
(New Position)
Filing
History
2021-12-20
4:52 pm
Purchase
2021-12-1613GCULLINAN THERAPEUTICS INC
CGEM
BIOTECHNOLOGY VALUE FUND L P4,394,459
10.100%
1,787,653increase
(+68.58%)
Filing
History
2021-11-08
5:20 pm
Purchase
2021-10-2813GCULLINAN THERAPEUTICS INC
CGEM
BIOTECHNOLOGY VALUE FUND L P2,606,806
6.000%
2,606,806increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2